Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine Dose-Dependent Modulation of Lung Function and AQP1 Expression During One-Lung Ventilation in Adults Undergoing Thoracoscopic Surgery: A Randomized Controlled Trial

NCT07145814 is registered in ClinicalTrials.gov with People's Hospital of Guangxi Zhuang Autonomous Region as lead sponsor.

NCT NCT07145814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine Dose-Dependent Modulation of Lung Function and AQP1 Expression During One-Lung Ventilation in Adults Undergoing Thoracoscopic Surgery: A Randomized Controlled Trial
Lead sponsor
People's Hospital of Guangxi Zhuang Autonomous Region
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2018
Completion date
March 29, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury(ali)